*mymedicalexpo

Catalogs
Cepheid
Xpert® Xpress Flu/RSV 2023

Xpert® Xpress Flu/RSV 2023

Product catalog summary

Introduction
The document discusses the Xpert® Xpress Flu/RSV test by Cepheid, a CE-IVD certified in vitro diagnostic medical device designed for rapid and accurate detection of influenza (Flu A and B) and respiratory syncytial virus (RSV). It highlights the need for precise differentiation between these infections due to similar clinical symptoms and the limitations of existing rapid tests.

The Need
Influenza and RSV present similar symptoms across all ages, complicating diagnosis. Current rapid tests have limited sensitivity, with Flu tests ranging from 50-70% and RSV tests averaging 29% in adults. Manufacturers recommend confirming negative results with RT-PCR or culture due to these limitations.

The Solution
The Xpert® Xpress Flu/RSV test offers single-test confidence, enhancing laboratory workflow with on-demand, random-access flexibility. It provides accurate detection of Flu A, Flu B, and RSV in as little as 20 minutes, enabling quick delivery of targeted therapies and improving patient satisfaction.

Benefits
The test streamlines laboratory operations, improves patient management, and supports antibiotic and antiviral stewardship. It offers early assay termination options, delivering positive results in 20 minutes and negative results in 30 minutes.

Impact on Healthcare
The test impacts patient admission and management in emergency departments and outpatient pathways by providing timely, actionable information to clinicians, thus optimizing patient management and improving satisfaction.

Workflow
The testing process involves three steps: obtaining the specimen, transferring the sample to the cartridge, and starting the test. Results are delivered quickly, enhancing laboratory efficiency.

Contact Information
Corporate and European headquarters contact details are provided for further inquiries.

References
The document cites various studies and guidelines to support the efficacy and necessity of the Xpert® Xpress Flu/RSV test.

Catalog excerpts

Fast Diagnosis When it Matters Most Xpert® Test Xpress 15/19 Flu/RSV Cepheid Bold CE-IVD. CE-IVD. In In Vitro Vitro Diagnostic Diagnostic Medical Medical Device. Device. Not Not available available in in all all countries. countries. 2797

Open the catalog to page 1

Xpert® Xpress Flu/RSV • In patients of all ages, influenza and RSV often present with similar clinical symptoms, making it difficult to differentiate between the two infections¹ • Accurate and reliable detection of Flu A, Flu B and RSV in as soon as 20 minutes* • Sensitivities of Rapid EIA Flu tests range from 50−70%² • Sensitivities of Rapid Antigen RSV tests average 29% in adults³ • Enables healthcare providers to quickly deliver targeted therapies • Streamlines laboratory operations • Improves patient satisfaction • Both Rapid EIA and Antigen manufacturers suggest confirming negative results...

Open the catalog to page 2

Coverage, plus Accuracy, plus Peace of mind That’s the PCRplus advantage. From Cepheid. Impact on Outpatient Pathway Improving Patient Satisfaction Xpert® Xpress Flu/RSV provides medically actionable and timely information to clinicians to support improved patient management and antibiotic and antiviral stewardship. Elapsed (mins) Specimen collected and sent for testing Xpert PCR with positive results in as soon as 20 minutes* Patient Pathway Results delivered to clinician/ patient Optimal patient management FLU A +/FLU B +/RSV +/- OR NEGATIVE Impact on Patient Admission & Management at Emergency...

Open the catalog to page 3

Workflow: 3 Easy Steps 1 Obtain specimen stored in appropriate transport medium or saline Transfer sample to cartridge Insert cartridge and start test CATALOG INFORMATION Xpert® Xpress Flu/RSV SPECIMEN KITS REQUIRED FOR PRIMARY SAMPLE COLLECTION AND TREATMENT CATALOG INFORMATION Nasopharyngeal swab and Transport medium Regular flocked swab w/UTM * For positive Flu only or RSV only. Reporting negatives and combined reporting in 30 minutes. References: 1 Falsey AR, Walsh EE. Respiratory Syncytial Virus Infection in Adults. Clin Microbiol Rev. 2000 Jul; 13. 2 CDC. Guidance for Clinicians on the...

Open the catalog to page 4

All Cepheid catalogs and technical brochures

Archived catalogs

*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.

Brand list